PFOS and Its Commercial Alternative, 6:2 Cl-PFESA, Induce Multidrug Resistance in Pancreatic Cancer

胰腺癌 多重耐药 抗性(生态学) 癌症 癌症研究 医学 内科学 药理学 生物 微生物学 抗药性 生态学
作者
Jiawei Hong,Keyi Du,Weichen Zhang,Yifan Jiang,Hanxi Yu,Tingting Pan,Tong Wu,Liang Zhao,Wei Du,Shusen Zheng,Hangbiao Jin,Yuanchen Chen,Linping Cao
出处
期刊:Environmental Science & Technology [American Chemical Society]
卷期号:58 (50): 22027-22038 被引量:14
标识
DOI:10.1021/acs.est.4c08669
摘要

Per- and polyfluoroalkyl substances (PFAS), specifically perfluorooctanesulfonate (PFOS) and its alternative, 2-[(6-chloro-1,1,2,2,3,3,4,4,5,5,6,6-dodecafluorohexyl)oxy]-1,1,2,2-tetrafluoroethanesulfonic acid (6:2 Cl-PFESA), are associated with environmental health concerns and potential cancer progression. However, their impact on multidrug resistance (MDR) in pancreatic cancer (PC) chemotherapy remains unclear. Here, we employed drug-sensitivity assays, including IC 50 calculations, in vitro and in vivo models with various chemotherapeutics, and paclitaxel (PTX) as a representative agent, combined with transcriptomic/proteomic sequencing and clinical prognostic analysis, to identify MDR-related genes and validate their relevance, with the objective of establishing the correlation between PFOS/6:2 Cl-PFESA exposure and MDR in PC at molecular, cellular, and animal model levels. Our findings demonstrate that PFOS/6:2 Cl-PFESA exposure increases the drug IC 50 in three different PC cell lines for various chemotherapeutic agents. Compared with PFOS, 6:2 Cl-PFESA demonstrated a more pro-MDR effect on PC cells in vitro . In vivo experiments further revealed that PFOS/6:2 Cl-PFESA exposures significantly reduced the efficacy of PTX in PC, with inhibition rates dropping from 78.3% to 23.8%/6.1%, respectively ( p < 0.05). This effect was driven by the aberrant activation of the PI3K–ABCB1 pathway, with 6:2 Cl-PFESA demonstrating a stronger capacity to promote this signal pathway’s expression and function compared with PFOS. These data suggest that exposure to PFAS may elevate the risk of MDR and subsequent disease progression. Although marketed as a safer alternative to PFOS, the notable impact of 6:2 Cl-PFESA on MDR highlights the necessity for a comprehensive assessment of its potential carcinogenic risks.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
吃肯德基发布了新的文献求助10
刚刚
刚刚
4u完成签到,获得积分10
3秒前
Kikisman发布了新的文献求助10
4秒前
xuz完成签到,获得积分10
4秒前
cc完成签到,获得积分10
5秒前
和谐的尔琴完成签到,获得积分10
5秒前
NexusExplorer的应助被壮观的雨泽采纳,获得10
5秒前
Wim发布了新的文献求助10
6秒前
xz完成签到,获得积分20
8秒前
科目三的应助被阿梨采纳,获得10
8秒前
CipherSage的应助被stackheap采纳,获得10
9秒前
10秒前
吨吨完成签到,获得积分10
10秒前
满意的文涛完成签到 ,获得积分10
10秒前
简单的冬瓜完成签到 ,获得积分10
10秒前
无花果的应助被苏木采纳,获得10
10秒前
852的应助被theverve采纳,获得10
11秒前
Hello的应助被十三月采纳,获得10
12秒前
13秒前
小橙子完成签到 ,获得积分10
13秒前
Godwin发布了新的文献求助10
14秒前
酷波er的应助被灵巧小松鼠采纳,获得30
14秒前
wanci的应助被璃月品茶钟离采纳,获得10
14秒前
14秒前
14秒前
旺仔QQ糖完成签到,获得积分10
14秒前
田田田田发布了新的文献求助10
15秒前
思源的应助被宋清华采纳,获得10
15秒前
莫欣宇完成签到 ,获得积分10
16秒前
16秒前
1618完成签到,获得积分20
17秒前
18秒前
假发君发布了新的文献求助10
18秒前
fortuna发布了新的文献求助10
19秒前
19秒前
20秒前
20秒前
王蕊发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158017
求助须知:如何正确求助?哪些是违规求助? 9553900
关于积分的说明 21716555
捐赠科研通 7747340
什么是DOI,文献DOI怎么找? 3426934
关于科研通互助平台的介绍 2551639
邀请新用户注册赠送积分活动 2471005